Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Cancer, Cell and Gene Therapy, Biologics
Elucidating critical anti-tumor immunity pathways via imaging-based cytotoxicity assays.
October 17, 2025 -
4 min read
Biologics
Three productivity advantages of switching to transposon-based integration.
July 18, 2025 -
4 min read
Biologics
How to improve plasmid DNA quality control to accelerate RNA innovation.
June 6, 2025 -
3 min read
Cell and Gene Therapy, Biologics, Cancer
Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.
April 2, 2025 -
3 min read
Biologics
The economic factors shaping expression system decisions and manufacturing strategies.
March 24, 2025 -
3 min read
Biologics
Trends and innovations: new insights from the 2024 bioprocessing summit (BPS) and bioprocess international (BPI) conferences.
November 4, 2024 -
3 min read
Cell and Gene Therapy, Biologics, Infectious Diseases
Taking advantage of viral cytopathic effects to aid in the rapid screening of effective viral therapies.
September 30, 2024 -
3 min read
Cell and Gene Therapy, Biologics, Cancer
What is Image Cytometry?
September 27, 2024 -
4 min read
